Zevra Therapeutics (ZVRA) Institutional Ownership

$12.01 -0.05 (-0.41%)

Closing price 09/11/2026 04:00 PM Eastern

Extended Trading

$12.01 0.00 (0.00%)

As of 09/11/2026 07:30 PM Eastern

Compare

Current Institutional Ownership Percentage: 35.03%
Number of Institutional Buyers (last 12 months): 75
Total Institutional Inflows (last 12 months): $100.81M

Number of Institutional Sellers (last 12 months): 35
Total Institutional Outflows (last 12 months): $42.98M

Get ZVRA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Zevra Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ZVRA Institutional Buying and Selling by Quarter

Zevra Therapeutics Major Shareholders & Ownership History

Export

Reporting Date	Major Shareholder Name	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/9/2026	Tidal Investments LLC	10,458	$150K	0.0%	N/A	0.018%
9/9/2026	WINTON GROUP Ltd	24,335	$349K	0.0%	+49.0%	0.041%
9/9/2026	Integrated Wealth Concepts LLC	1,977	$28K	0.0%	N/A	0.003%
8/24/2026	California State Teachers Retirement System	11,200	$161K	0.0%	+271.5%	0.019%
8/19/2026	Wellington Management Group LLP	164,538	$2.36M	0.0%	+5.2%	0.277%
8/13/2026	Globeflex Capital L P	191,904	$2.75M	0.4%	N/A	0.323%
8/6/2026	Bank of New York Mellon Corp	198,432	$2.85M	0.0%	N/A	0.336%
7/9/2026	Hennion & Walsh Asset Management Inc.	383,706	$5.50M	0.2%	+116.6%	0.649%
5/20/2026	Arete Wealth Advisors LLC	66,397	$617K	0.0%	-4.8%	0.112%
5/19/2026	Bank of America Corp DE	64,837	$604K	0.0%	-55.7%	0.110%
Get the Latest News and Ratings for ZVRA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Zevra Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
5/19/2026	Arete Wealth Advisors LLC	66,397	$617K	0.0%	-4.8%	0.112%
5/16/2026	The Manufacturers Life Insurance Company	15,137	$141K	0.0%	-10.4%	0.026%
5/16/2026	Quantinno Capital Management LP	32,022	$298K	0.0%	+114.1%	0.054%
5/7/2026	Dimensional Fund Advisors LP	554,802	$5.17M	0.0%	+259.2%	0.938%
5/5/2026	Bank of New York Mellon Corp	172,427	$1.61M	0.0%	-1.0%	0.292%
5/5/2026	Sanctuary Advisors LLC	18,490	$172K	0.0%	-46.3%	0.031%
4/30/2026	AIGH Capital Management LLC	1,200,000	$11.18M	1.5%	N/A	2.030%
4/27/2026	Simplify Asset Management Inc.	100,630	$938K	0.0%	+137.5%	0.170%
4/22/2026	Janney Montgomery Scott LLC	236,834	$2.21M	0.0%	+16.7%	0.403%
3/5/2026	Gunpowder Capital Management LLC dba Oliver Wealth Management	5,891	$53K	0.0%	N/A	0.010%
2/24/2026	DGS Capital Management LLC	14,810	$133K	0.0%	N/A	0.026%
2/18/2026	NewEdge Advisors LLC	4,000	$36K	0.0%	-82.1%	0.007%
2/18/2026	Wellington Management Group LLP	170,309	$1.53M	0.0%	-9.1%	0.303%
2/18/2026	Polymer Capital Management US LLC	17,123	$153K	0.0%	-46.0%	0.030%
2/18/2026	Millennium Management LLC	1,134,358	$10.16M	0.0%	+9.6%	2.015%
2/18/2026	Man Group plc	92,347	$827K	0.0%	+174.4%	0.164%
2/18/2026	Engineers Gate Manager LP	44,020	$394K	0.0%	+23.4%	0.078%
2/18/2026	683 Capital Management LLC	905,000	$8.11M	0.4%	-7.2%	1.607%
2/17/2026	Schonfeld Strategic Advisors LLC	13,824	$124K	0.0%	N/A	0.025%
2/17/2026	AQR Capital Management LLC	181,129	$1.62M	0.0%	+18.9%	0.322%
2/17/2026	Trexquant Investment LP	209,704	$1.88M	0.0%	-30.8%	0.372%
2/17/2026	Price T Rowe Associates Inc. MD	32,140	$288K	0.0%	+12.8%	0.057%
2/17/2026	Adage Capital Partners GP L.L.C.	275,000	$2.46M	0.0%	-87.6%	0.488%
2/17/2026	Royal Bank of Canada	4,582	$42K	0.0%	-52.7%	0.008%
2/17/2026	Carret Asset Management LLC	54,000	$484K	0.0%	-5.3%	0.096%
2/16/2026	Squarepoint Ops LLC	317,066	$2.84M	0.0%	+18.3%	0.563%
2/16/2026	Verition Fund Management LLC	17,704	$159K	0.0%	-90.9%	0.031%
2/16/2026	Barclays PLC	100,135	$897K	0.0%	-69.9%	0.178%
2/13/2026	Arete Wealth Advisors LLC	69,769	$625K	0.0%	-6.1%	0.124%
2/13/2026	Nantahala Capital Management LLC	1,771,936	$15.88M	0.5%	-10.1%	3.147%
Elon Musk to Trigger Next AI Wave on November 11th? (Ad) Jeff Brown picked Nvidia in 2016, before shares surged 37,800 percent. Now he's identified another AI company the same size Nvidia was a decade ago. Brown says this firm's patented technology can produce intelligence up to 1,000 times faster than standard AI, and he expects Elon Musk to fuel demand starting November 11. The technology is protected by 150 patents. See Jeff Brown's full research on this AI stock now
2/13/2026	Marshall Wace LLP	669,742	$6.00M	0.0%	-26.6%	1.190%
2/13/2026	The Manufacturers Life Insurance Company	16,896	$151K	0.0%	-9.5%	0.030%
2/13/2026	Schroder Investment Management Group	506,033	$4.46M	0.0%	+22.7%	0.899%
2/13/2026	Rafferty Asset Management LLC	15,920	$143K	0.0%	+34.0%	0.028%
2/13/2026	Charles Schwab Investment Management Inc.	180,618	$1.62M	0.0%	+14.5%	0.321%
2/13/2026	State Street Corp	1,482,956	$13.29M	0.0%	+3.9%	2.634%
2/13/2026	Wells Fargo & Company MN	66,950	$600K	0.0%	+81.7%	0.119%
2/12/2026	MetLife Investment Management LLC	27,867	$250K	0.0%	+10.5%	0.049%
2/12/2026	Commonwealth Equity Services LLC	14,229	$127K	0.0%	-45.2%	0.025%
2/12/2026	Dimensional Fund Advisors LP	154,466	$1.38M	0.0%	N/A	0.274%
2/12/2026	EntryPoint Capital LLC	52,871	$474K	0.2%	+83.1%	0.094%
2/12/2026	Integrated Quantitative Investments LLC	56,128	$503K	0.1%	N/A	0.100%
2/12/2026	Federated Hermes Inc.	23,453	$210K	0.0%	+17.8%	0.042%
2/12/2026	Nuveen LLC	143,132	$1.28M	0.0%	-6.5%	0.254%
2/11/2026	Janney Montgomery Scott LLC	202,883	$1.82M	0.0%	+10.4%	0.360%
2/11/2026	Deutsche Bank AG	45,939	$412K	0.0%	+4.4%	0.082%
2/11/2026	Fox Run Management L.L.C.	24,722	$222K	0.0%	-20.3%	0.044%
2/11/2026	JPMorgan Chase & Co.	412,261	$3.69M	0.0%	-6.1%	0.732%
2/11/2026	Los Angeles Capital Management LLC	54,454	$488K	0.0%	-7.0%	0.097%
2/11/2026	Propel Bio Management LLC	63,683	$571K	0.5%	-72.5%	0.113%
2/11/2026	WINTON GROUP Ltd	26,089	$234K	0.0%	+114.5%	0.046%
2/10/2026	Northwestern Mutual Wealth Management Co.	15,000	$134K	0.0%	N/A	0.027%
2/9/2026	Geode Capital Management LLC	1,341,681	$12.03M	0.0%	+3.2%	2.383%
2/9/2026	Royce & Associates LP	865,822	$7.76M	0.1%	+25.3%	1.538%
2/9/2026	Legal & General Group Plc	1,097,988	$9.84M	0.0%	+4.2%	1.950%
2/9/2026	Simplify Asset Management Inc.	42,365	$380K	0.0%	-71.2%	0.075%
2/9/2026	Jefferies Financial Group Inc.	120,000	$1.08M	0.0%	N/A	0.213%
2/6/2026	ProShare Advisors LLC	12,669	$114K	0.0%	+12.3%	0.023%
2/4/2026	Bailard Inc.	12,900	$116K	0.0%	N/A	0.023%
1/29/2026	UBS Group AG	285,488	$2.56M	0.0%	+30.9%	0.507%
1/29/2026	Sanctuary Advisors LLC	34,461	$309K	0.0%	+18.0%	0.061%
1/28/2026	Retirement Planning Co of New England Inc.	662,976	$5.94M	2.4%	+10.4%	1.178%
1/20/2026	Stratos Wealth Partners LTD.	409,000	$3.67M	0.0%	+78.6%	0.726%
1/14/2026	Hennion & Walsh Asset Management Inc.	139,591	$1.25M	0.0%	N/A	0.248%
1/9/2026	SG Americas Securities LLC	13,543	$121K	0.0%	N/A	0.024%
1/1/2026	JPMorgan Chase & Co.	438,984	$4.18M	0.0%	+1,458.8%	0.780%
12/1/2025	Cantor Fitzgerald L. P.	117,576	$1.12M	0.0%	+487.9%	0.209%
11/17/2025	NewEdge Advisors LLC	22,338	$212K	0.0%	+458.5%	0.040%
11/17/2025	Caxton Associates LLP	17,317	$165K	0.0%	N/A	0.031%
11/17/2025	Woodline Partners LP	3,476,143	$33.06M	0.2%	-24.7%	6.175%
11/17/2025	PharVision Advisers LLC	66,733	$635K	0.4%	N/A	0.119%
11/17/2025	XTX Topco Ltd	66,381	$631K	0.0%	N/A	0.118%
11/17/2025	Verition Fund Management LLC	193,509	$1.84M	0.0%	N/A	0.344%
11/17/2025	Polymer Capital Management US LLC	31,698	$301K	0.0%	+89.4%	0.056%
11/17/2025	Quarry LP	10,883	$103K	0.0%	N/A	0.019%
11/17/2025	Qube Research & Technologies Ltd	306,489	$2.92M	0.0%	+2,615.2%	0.544%
11/17/2025	Prelude Capital Management LLC	15,600	$148K	0.0%	N/A	0.028%
11/17/2025	Nantahala Capital Management LLC	1,971,936	$18.75M	0.7%	+34.0%	3.503%
11/17/2025	Millennium Management LLC	1,035,251	$9.85M	0.0%	+63.1%	1.839%
11/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	24,896	$237K	0.0%	-17.7%	0.044%
Why the Treasury still prices gold at 42 dollars an ounce (Ad) The U.S. Treasury still values its gold reserves at 42.22 dollars an ounce, a price set in 1973. Gold trades near 4,500 dollars today, a 113-to-1 gap between book value and market reality. Treasury Secretary Scott Bessent has said he wants to monetize the asset side of the balance sheet. A revaluation could add more than 1 trillion dollars to the government's books overnight. Certain gold miners still trade as if gold were under 2,000 dollars, even as prices near record highs. See the four gold miners positioned ahead of a potential Treasury revaluation.
11/17/2025	Integrated Wealth Concepts LLC	15,081	$143K	0.0%	N/A	0.027%
11/17/2025	Kingdon Capital Management L.L.C.	650,000	$6.18M	0.8%	+44.4%	1.155%
11/17/2025	Brevan Howard Capital Management LP	130,751	$1.24M	0.0%	N/A	0.232%
11/17/2025	Cantor Fitzgerald L. P.	117,576	$1.12M	0.0%	+487.9%	0.209%
11/17/2025	Bank of America Corp DE	288,045	$2.74M	0.0%	+28.7%	0.512%
11/17/2025	Boothbay Fund Management LLC	14,943	$142K	0.0%	N/A	0.027%
11/17/2025	Aquatic Capital Management LLC	28,593	$272K	0.0%	-11.5%	0.051%
11/17/2025	Algert Global LLC	418,550	$3.98M	0.1%	N/A	0.743%
11/14/2025	Raymond James Financial Inc.	23,306	$222K	0.0%	-13.4%	0.041%
11/14/2025	Virtu Financial LLC	62,740	$597K	0.0%	N/A	0.111%

ZVRA Institutional Ownership - Frequently Asked Questions

During the previous two years, 123 institutional investors and hedge funds held shares of Zevra Therapeutics. The most heavily invested institutionals were Woodline Partners LP ($33.06M), Vanguard Group Inc. ($29.32M), Rubric Capital Management LP ($17.25M), FMR LLC ($16.05M), Nantahala Capital Management LLC ($15.88M), State Street Corp ($13.29M), and Geode Capital Management LLC ($12.03M).Learn more on Zevra Therapeutics' institutional investors.

35.03% of Zevra Therapeutics' stock is owned by institutional investors. Learn more on ZVRA's institutional investor holdings.

Of the 113 institutional investors that purchased Zevra Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Adage Capital Partners GP L.L.C. ($3.55M), AIGH Capital Management LLC ($2.64M), FMR LLC ($2.31M), Marshall Wace LLP ($912.30K), Stonepine Capital Management LLC ($877.92K), Royce & Associates LP ($865.82K), and JPMorgan Chase & Co. ($830.87K).

Institutional investors have bought a total of 10,408,126 shares in the last 24 months. This purchase volume represents approximately $100.81M in transactions.

Of the 35 institutional investors that sold Zevra Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Adage Capital Partners GP L.L.C. ($1.95M), Woodline Partners LP ($1.14M), Marshall Wace LLP ($242.56K), Barclays PLC ($232.31K), Nantahala Capital Management LLC ($200K), Verition Fund Management LLC ($175.81K), and Propel Bio Management LLC ($168.19K).

Institutional investors have sold a total of 4,716,001 shares in the last 24 months. This volume of shares sold represents approximately $42.98M in transactions.

Related Companies

Institutional ownership data for NASDAQ:ZVRA is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 9/9/2026. New 13F filings are added each quarter as they're published.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Zevra Therapeutics (ZVRA) Institutional Ownership

ZVRA Institutional Buying and Selling by Quarter

Zevra Therapeutics Major Shareholders & Ownership History

ZVRA Institutional Ownership - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Zevra Therapeutics (ZVRA) Institutional Ownership

Institutional Ownership Changes (13F Filings) for Zevra Therapeutics (NASDAQ:ZVRA)

ZVRA Institutional Buying and Selling by Quarter

Zevra Therapeutics Major Shareholders & Ownership History

ZVRA Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ZVRA shares?

What percentage of Zevra Therapeutics' stock is owned by institutional investors?

Which institutional investors have been buying Zevra Therapeutics' stock?

How much institutional buying is happening at Zevra Therapeutics?

Which of Zevra Therapeutics' major shareholders have been selling company stock?

How much institutional selling is happening at Zevra Therapeutics?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools